Angiotensin I Is Largely Converted to Angiotensin (1-7) and Angiotensin (2-10) by Isolated Rat Glomeruli
- 1 May 2009
- journal article
- research article
- Published by Wolters Kluwer Health in Hypertension
- Vol. 53 (5) , 790-797
Abstract
Intraglomerular renin-angiotensin system enzyme activities have been examined previously using glomerular lysates and immune-based assays. However, preparation of glomerular extracts compromises the integrity of their anatomic architecture. In addition, antibody-based assays focus on angiotensin (Ang) II detection, ignoring the generation of other Ang I–derived metabolites, some of which may cross-react with Ang II. Therefore, our aim was to examine the metabolism of Ang I in freshly isolated intact glomeruli using matrix-assisted laser desorption ionization time of flight mass spectrometry as an analytic method. Glomeruli from male Sprague-Dawley rats were isolated by sieving and incubated in Krebs buffer in the presence of 1 μmol/L of Ang I for 15 to 90 minutes, with or without various peptidase inhibitors. Peptide sequences were confirmed by matrix-assisted laser desorption ionization time of flight tandem mass spectrometry or linear-trap-quadrupole mass spectrometry. Peaks were quantified using customized valine- 13 C ·15 N-labeled peptides as standards. The most prominent peaks resulting from Ang I cleavage were 899 and 1181 m/z , corresponding with Ang (1-7) and Ang (2-10), respectively. Smaller peaks for Ang II, Ang (1-9), and Ang (3-10) also were detected. The disappearance of Ang I was significantly reduced during inhibition of aminopeptidase A or neprilysin. In contrast, captopril did not alter Ang I degradation. Furthermore, during simultaneous inhibition of aminopeptidase A and neprilysin, the disappearance of Ang I was markedly attenuated compared with all of the other conditions. These results suggest that there is prominent intraglomerular conversion of Ang I to Ang (2-10) and Ang (1-7), mediated by aminopeptidase A and neprilysin, respectively. Formation of these alternative Ang peptides may be critical to counterbalance the local actions of Ang II. Enhancement of these enzymatic activities may constitute potential therapeutic targets for Ang II–mediated glomerular diseases.Keywords
This publication has 38 references indexed in Scilit:
- ACE-Dependent and Chymase-Dependent Angiotensin II Generation in Normal and Glucose-Stimulated Human Mesangial CellsExperimental Biology and Medicine, 2008
- Characterization of renin-angiotensin system enzyme activities in cultured mouse podocytesAmerican Journal of Physiology-Renal Physiology, 2007
- Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin IIAmerican Journal of Physiology-Renal Physiology, 2007
- ACE and ACE2 Activity in Diabetic MiceDiabetes, 2006
- A novel mechanism for angiotensin II formation in streptozotocin-diabetic rat glomeruliAmerican Journal of Physiology-Renal Physiology, 2005
- The role of angiotensin converting enzyme 2 in the generation of angiotensin 1–7 by rat proximal tubulesAmerican Journal of Physiology-Renal Physiology, 2005
- Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpressionAmerican Journal of Physiology-Endocrinology and Metabolism, 2005
- Neutral endopeptidase expression in mesangial cellsJournal of the Renin-Angiotensin-Aldosterone System, 2003
- Differential regulation of angiotensin peptide levels in plasma and kidney of the rat.Hypertension, 1991
- Endogenous angiotensin concentrations in specific intrarenal fluid compartments of the rat.Journal of Clinical Investigation, 1990